insider24.ch
Back to the feed

Shareholding disclosure

HBM BioVentures AG

inBasilea Pharmaceutica AG, Allschwil

Declared position

15.23%

Threshold

Crossed upwards

Timeline

Published

17.09.2011

Transaction

14.09.2011

Voting rights breakdown

Voting rights acquired15.23%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAB9F00092

Beneficial owner

HBM BioVentures AG

Declared address

HBM BioVentures AG, 6300 Zug

Bei HBM BioVentures (Cayman) Ltd handelt es sich um eine hundertprozentige Tochtergesellschaft der HBM BioVentures AG, Zug. Die gemeldete Beteiligung wird direkt von der HBM BioVentures (Cayman) Ltd gehalten.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open